Clinical trials recruiting for Sjogren's Syndrome
25
Recruiting trials
9
US states with sites
9
Countries
24%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Maryland | 3 |
| Florida | 2 |
| Connecticut | 1 |
| Iowa | 1 |
| New York | 1 |
| North Carolina | 1 |
| Tennessee | 1 |
| Texas | 1 |
| Utah | 1 |
Top cities
Bethesda, Maryland 3Orlando, Florida 2Brooklyn, New York 1Durham, North Carolina 1Iowa City, Iowa 1Memphis, Tennessee 1New Haven, Connecticut 1Plano, Texas 1Salt Lake City, Utah 1Webster, Texas 1
Self-screener
Recruiting trials
- A Phase 1, First-in-Human Study of CND319 in Healthy Participants and Patients With Rheumatic Diseases
- A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease
- An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
- An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
- Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT
- Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
- Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments
- B-dependant Rare AutoImmune diseaSES - Cohort of Patients With Suspected Diagnosis of Primitive Sjögren Syndrome
- Belimumab After Rituximab in Resistant Primary Juvenile SS
- Characterization of Diseases With Salivary Gland Involvement
- Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
- Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
- Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
- Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome
- Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
- Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis
- Maternal Autoimmune Disease Research Alliance (MADRA) Registry
- Meir Medical Center Rheumatologic Biobank
- Rheumatology Diet Study
- Rheumatology Patient Registry and Biorepository
- Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease
- Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
- Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases
- The Pathogenesis and Natural History of Sjogren's Disease
- Ultra-High Frequency Ultrasonography in Sjögren's Syndrome
Related conditions
Trials recruiting for Sjogren's Syndrome often also study these conditions. Each links to its own recruiting-trial list.
Rheumatoid arthritis 314Lupus 332Systemic lupus erythematosus 119Systemic Sclerosis 27Autoimmune Diseases 29Psoriasis 233Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 9Scleroderma 9Psoriatic arthritis 45Antiphospholipid Syndrome 10
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Sjogren's Syndrome trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.